The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Oxidative stress promotes myofibroblast differentiation and tumour spreading
Open accessAbstract
JunD regulates genes involved in antioxidant defence. We took advantage of the chronic oxidative stress resulting from junD deletion to examine the role of reactive oxygen species (ROS) in tumour development. In a model of mammary carcinogenesis, junD inactivation increased tumour incidence and revealed an associated reactive stroma. junD-inactivation in the stroma was sufficient to shorten tumour-free survival rate and enhance metastatic spread. ROS promoted conversion of fibroblasts into highly migrating myofibroblasts through accumulation of the hypoxia-inducible factor (HIF)-1alpha transcription factor and the CXCL12 chemokine. Accordingly, treatment with an antioxidant reduced the levels of HIF and CXCL12 and numerous myofibroblast features. CXCL12 accumulated in the stroma of HER2-human breast adenocarcinomas. Moreover, HER2 tumours exhibited a high proportion of myofibroblasts, which was significantly correlated to nodal metastases. Interestingly, this subset of tumours exhibited a significant nuclear exclusion of JunD and revealed an associated oxido-reduction signature, further demonstrating the relevance of our findings in human cancers. Collectively, our data uncover a new mechanism by which oxidative stress increases the migratory properties of stromal fibroblasts, which in turn potentiate tumour dissemination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CAFs and ROS engage in two-way cross-talk: on the one hand, fibroblasts are targeted by ROS, particularly H2O2, which is able to convert them into active CAFs through the upregulation of HIF1α; on the other hand, CAFs are critical for the increase in ROS levels observed in cancer50,51.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Flagged first, then by citations
1 of the 91 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 340
BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment
Martinez‐Outschoorn, U., Balliet, R. M., Lin, Z., Whitaker‐Menezes, D., Birbe, R., Bombonati, A., Pavlides, S., Lamb, R., Sneddon, S., Howell, A., et al. (2012) · Cell Cycle · doi:10.4161/cc.22776 · Cited by 89
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
Veirman, K. D., Rao, L., Bruyne, E. D., Menu, E., Valckenborgh, E. V., Riet, I. V., Frassanito, M. A., Marzo, L. D., Vacca, A., & Vanderkerken, K. (2014) · Cancers · doi:10.3390/cancers6031363 · Cited by 86
Witkiewicz, A. K., Kline, J., Queenan, M., Brody, J. R., Tsirigos, A., Bilal, E., Pavlides, S., Ertel, A., Sotgia, F., & Lisanti, M. P. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15675 · Cited by 83
miR-205 Hinders the Malignant Interplay Between Prostate Cancer Cells and Associated Fibroblasts
Gandellini, P., Giannoni, E., Casamichele, A., Taddei, M. L., Callari, M., Piovan, C., Valdagni, R., Pierotti, M. A., Zaffaroni, N., & Chiarugi, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5292 · Cited by 81
Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
Cammarota, F., & Laukkanen, M. O. (2015) · Stem Cells International · doi:10.1155/2016/4824573 · Cited by 85
Ziani, L., Buart, S., Chouaı̈b, S., & Thiery, J. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1950953 · Cited by 82
α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion
Lei, J., Huo, X., Duan, W., Xu, Q., Li, R., Ma, J., Li, X., Han, L., Li, W., Sun, H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.003 · Cited by 79
Muchlińska, A., Nagel, A. C., Popęda, M., Szade, J., Niemira, M., Zieliński, J., Skokowski, J., Bednarz‐Knoll, N., & Zaczek, A. J. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00351-7 · Cited by 78
Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment
Zhi, S., Chen, C., Huang, H., Zhang, Z., Zeng, F., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370800 · Cited by 91
Taddei, M. L., Giannoni, E., Raugei, G., Scacco, S., Sardanelli, A. M., Papa, S., & Chiarugi, P. (2012) · Journal of Signal Transduction · doi:10.1155/2012/684592 · Cited by 71
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Bonneau, C., Eliès, A., Kieffer, Y., Bourachot, B., Ladoire, S., Pelon, F., Héquet, D., Guinebretière, J. M., Blanchet, C., Vincent‐Salomon, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01311-9 · Cited by 70
Self-citationThe Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors
Sonugür, F. G., & Akbulut, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01063 · Cited by 68
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
Murdamoothoo, D., Sun, Z., Yilmaz, A., Riegel, G., Fayçal, C. A., Deligne, C., Velázquez-Quesada, I., Erne, W., Nascimento, M., Mörgelin, M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013270 · Cited by 70
Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD
Hussain, S., Khan, A. W., Akhmedov, A. T., Suades, R., Costantino, S., Paneni, F., Caidahl, K., Mohammed, S. A., Hage, C., Gkolfos, C., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317132 · Cited by 69
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 70
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Ciepła, J., & Smolarczyk, R. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01501-1 · Cited by 81
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 74
Dual-Responsive Molecular Probe for Tumor Targeted Imaging and Photodynamic Therapy
Meng, X., Yang, Y., Zhou, L., Zhang, L., Lv, Y., Li, S., Wu, Y., Zheng, M., Li, W., Gao, G., et al. (2017) · Theranostics · doi:10.7150/thno.18437 · Cited by 68
Myofibroblasts: Master of disguise
Bagalad, B., Kumar, K. M., & Puneeth, H. (2017) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_146_15 · Cited by 67
Shao, S. H., Duan, W., Xu, Q., Li, X., Han, L., Li, W., Zhang, D., Wang, Z., & Lei, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8148510 · Cited by 67
Stromal fibroblasts induce metastatic tumor cell clusters via epithelial–mesenchymal plasticity
Matsumura, Y., Ito, Y., Mezawa, Y., Sulidan, K., Daigo, Y., Hiraga, T., Mogushi, K., Wali, N., Suzuki, H., Itoh, T., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900425 · Cited by 66
Balzer, J., Heuer, K., Demir, E., Hoffmanns, M. A., Baldus, S., Fuchs, P. C., Awakowicz, P., Suschek, C. V., & Opländer, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144968 · Cited by 69
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 65
Licaj, M., Mhaidly, R., Kieffer, Y., Croizer, H., Bonneau, C., Meng, A., Djerroudi, L., Mujangi-Ebeka, K., Hocine, H. R., Bourachot, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45595-3 · Cited by 71
Self-citationOxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050282 · Cited by 71
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
Penkert, J., Ripperger, T., Schieck, M., Schlegelberger, B., Steinemann, D., & Illig, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11759 · Cited by 64
Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
Yang, B., & Chen, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6545728 · Cited by 61
Mezawa, Y., & Orimo, A. (2021) · FEBS Journal · doi:10.1111/febs.15851 · Cited by 59
Significance of myofibroblasts in oral squamous cell carcinoma
Thode, C., Jørgensen, T. G., Dabelsteen, E., Mackenzie, I. C., & Dabelsteen, S. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2010.00999.x · Cited by 57
Gruosso, T., Garnier, C., Abélanet, S., Kieffer, Y., Lemesre, V., Bellanger, D., Bièche, I., Marangoni, E., Sastre‐Garau, X., Mieulet, V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9583 · Cited by 70
Self-citationGenetic instability in the tumor microenvironment: a new look at an old neighbor
Palumbo, A., Costa, N. M. D., Bonamino, M., Pinto, L. F. R., & Nasciutti, L. E. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0409-y · Cited by 60
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer
Scognamiglio, I., Cocca, L., Puoti, I., Palma, F., Ingenito, F., Quintavalle, C., Affinito, A., Roscigno, G., Nuzzo, S., Chianese, R. V., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.013 · Cited by 55
Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer
Kwon, Y. (2021) · Antioxidants · doi:10.3390/antiox10020169 · Cited by 58
Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
Lior, C., Barki, D., Halperin, C., Iacobuzio–Donahue, C. A., Kelsen, D. P., & Scherz‐Shouval, R. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114236 · Cited by 59
Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness
Comito, G., Giannoni, E., Gennaro, P. D., Segura, C. P., Gerlini, G., & Chiarugi, P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.025 · Cited by 56
Gao, D., Fang, L., Liu, C., Yang, M., Yu, X., Wang, L., Zhang, W., Sun, C., & Zhuang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115622 · Cited by 52
Hull, R., Srivastava, P. K., D’Souza, Z., Atanur, S. S., Mechta‐Grigoriou, F., Gamé, L., Petretto, E. G., Cook, H. T., Aitman, T. J., & Behmoaras, J. V. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-92 · Cited by 52
Self-citationAnsardamavandi, A., & Tafazzoli‐Shadpour, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119103 · Cited by 53
Breau, M., Houssaini, A., Lipskaia, L., Abid, S., Born, E., Marcos, É., Czibik, G., Attwe, A., Beaulieu, D., Palazzo, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127647 · Cited by 52
Self-citationCancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
Lee, Y. T., Tan, Y. J., Falasca, M., & Oon, C. E. (2020) · Cancers · doi:10.3390/cancers12102949 · Cited by 50
Reactive oxygen species in cancer: Mechanistic insights and therapeutic innovations
Ma, N., Wang, Y., Li, X., Xu, M., & Tan, D. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100108 · Cited by 60
Papait, A., Stefani, F. R., Cargnoni, A., Magatti, M., Parolini, O., & Silini, A. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00447 · Cited by 52
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
Self-citationCarito, V., Bonuccelli, G., Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Caroleo, M. C., Cione, E., Howell, A., Pestell, R. G., Lisanti, M. P., & Sotgia, F. (2012) · Cell Cycle · doi:10.4161/cc.21701 · Cited by 50
Physiological and Therapeutical Roles of Ginger and Turmeric on Endocrine Functions
Al-Suhaimi, E. A., Al-Riziza, N. A., & Al-Essa, R. A. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x11008762 · Cited by 50
Cancer-associated fibroblasts and macrophages
Chiarugi, P. (2013) · OncoImmunology · doi:10.4161/onci.25563 · Cited by 48
Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1690 · Cited by 49
Self-citationSalminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 50
Redox Molecular Machines Involved in Tumor Progression
Parri, M., & Chiarugi, P. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5040 · Cited by 47
Giannoni, E., Taddei, M. L., Parri, M., Bianchini, F., Santosuosso, M., Grifantini, R., Fibbi, G., Mazzanti, B., Calorini, L., & Chiarugi, P. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0941-9 · Cited by 47
Caveolin-1 is a Modulator of Fibroblast Activation and a Potential Biomarker for Gastric Cancer
Shen, X., Zhang, H., Tang, G., Wang, X., Zheng, R., Wang, Y., Zhu, Y., Xue, X., & Bi, J. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10666 · Cited by 46
Parascandolo, A., Rappa, F., Cappello, F., Kim, J., Cantu, D. A., Chen, H., Mazzoccoli, G., Hematti, P., Castellone, M. D., Salvatore, M., et al. (2017) · Scientific Reports · doi:10.1038/srep41416 · Cited by 47
Xu, Y., Li, W., Lin, S., Liu, B., Wu, P., & Li, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01204-2 · Cited by 50
Redox regulation of cancer stem cells: Biology and therapeutic implications
Du, M., Zhang, J., Wicha, M. S., & Luo, M. (2024) · MedComm – Oncology · doi:10.1002/mog2.70005 · Cited by 45
Ren, Y. T., Zhou, X., Liu, X., Jia, H.-H., Zhao, X., Wang, Q.-X., Han, L., Song, X., Zhu, Z.-Y., Sun, T., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.003 · Cited by 45
Roles of caveolin-1 on anoikis resistance in non small cell lung cancer.
Chunhacha, P., & Pithi Chanvorachote, B. (2012) · Europe PMC (PubMed Central) · Cited by 43
Study on the Apoptosis Mechanism Induced by T-2 Toxin
Zhuang, Z., Yang, D., Huang, Y., & Wang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083105 · Cited by 43
Carvacrol and Pomegranate Extract in Treating Methotrexate-Induced Lung Oxidative Injury in Rats
Kaplan, İ. (2014) · Medical Science Monitor · doi:10.12659/msm.890972 · Cited by 42
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
Pestell, T. G., Jiao, X., Kumar, M., Peck, A. R., di Prisco, M., Deng, S., Li, Z., Ertel, A., Casimiro, M. C., Ju, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19953 · Cited by 44
Storrs, E. P., Chati, P., Usmani, A., Sloan, I. H., Krasnick, B. A., Babbra, R. K., Harris, P. K. W., Sachs, C. M., Qaium, F., Chatterjee, D., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00455-z · Cited by 48
Tang, P. C., Chan, M. K., Chung, J. Y., Chan, A. S. W., Zhang, D., Li, C., Leung, K. T., Ng, C. S. H., Wu, Y., To, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202302203 · Cited by 41
Magagna, I., Gourdin, N., Kieffer, Y., Licaj, M., Mhaidly, R., André, P., Morel, A., Vincent‐Salomon, A., Paturel, C., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13235878 · Cited by 40
Self-citationGomes, A. C. C. A., Mello, A. L. D. N., Ribeiro, M. G. L., Garcia, D. G., da Fonseca, C. O., Salazar, M. D., Schönthal, A. H., & Quírico‐Santos, T. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0459-5 · Cited by 39
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives
Toledo, B., Picon‐Ruiz, M., Marchal, J. A., & Perán, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415576 · Cited by 41
Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 49
Oxidative stress specifically downregulates survivin to promote breast tumour formation
Pervin, S., Tran, L., Urman, R., Braga, M., Parveen, M., Li, S., Chaudhuri, G., & Singh, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.40 · Cited by 38
Effects of photobiomodulation therapy on the extracellular matrix of human dental pulp cell sheets
Villavicencio, P. R. G., Pedroni, A. C. F., Cury, D. P., Moreira, M. S., Rosin, F. C. P., Sarra, G., & Marques, M. M. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.03.017 · Cited by 38
Kim, T., Kim, S., Kim, Y., Lee, Y., Lee, S., Lee, S.-H., & Kweon, M. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.015 · Cited by 39
The actin modulator hMENA regulates GAS6‐AXL axis and pro‐tumor cancer/stromal cell cooperation
Melchionna, R., Spada, S., Modugno, F. D., D’Andrea, D., Carlo, A. D., Panetta, M., Mileo, A. M., Sperduti, I., Antoniani, B., Gallo, E., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050078 · Cited by 36
Histone H2AX deficiency causes neurobehavioral deficits and impaired redox homeostasis
Weyemi, U., Paul, B. D., Snowman, A. M., Jailwala, P., Nussenzweig, A., Bonner, W. M., & Snyder, S. H. (2018) · Nature Communications · doi:10.1038/s41467-018-03948-9 · Cited by 37
The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts
Huang, Q., Ge, Y., He, Y. T., Wu, J., Tong, Y., Shang, H., Liu, X., Ba, X., Xia, D., Peng, E., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s447350 · Cited by 35
Saxena, A., Tammali, R., Ramana, K. V., & Sk, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4643 · Cited by 37
Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis
Liu, W., Wang, B., Zhou, M., Liu, D., Chen, F., Zhao, X., & Lu, Y. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0272 · Cited by 37
Main, E. N., Cruz, T. M., & Bowlin, G. L. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad070 · Cited by 34
Connecting the Human Microbiome and Pancreatic Cancer
Sexton, R. E., Uddin, M. H., Bannoura, S. F., Khan, H. Y., Mzannar, Y., Li, Y., Aboukameel, A., Al-Hallak, M. N., Al-Share, B. A., Mohamed, A., et al. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10022-w · Cited by 33
Liang, W., He, X., Bi, J., Hu, T., & Sun, Y. (2021) · Oncology Reports · doi:10.3892/or.2021.8159 · Cited by 34
D’Angelo, E., Lindoso, R. S., Sensi, F., Pucciarelli, S., Bussolati, B., Agostini, M., & Collino, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01122 · Cited by 35
Hwang, P. Y., Mathur, J., Cao, Y., de Almeida, J. A. A., Ye, J., Morikis, V. A., Cornish, D., Clarke, M., Stewart, S. A., Pathak, A., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2022.12.005 · Cited by 32
Batista, L., Gruosso, T., & Mechta‐Grigoriou, F. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.03.001 · Cited by 32
Self-citationZheng, L., Xu, C., Guan, Z., Su, X., Xu, Z., Cao, J., & Teng, L. (2016) · PubMed Central · Cited by 31
Alcaraz, L. B., Mallavialle, A., Mollévi, C., Boissière‐Michot, F., Mansouri, H., Simony-Lafontaine, J., Laurent‐Matha, V., Chardès, T., Jacot, W., Turtoï, A., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34345 · Cited by 31
Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy
Jung, H., & Paust, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1443366 · Cited by 31
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function
Hebert, L., Bellanger, D., Guillas, C., Campagne, A., Dingli, F., Loew, D., Fiévet, A., Jacquemin, V., Popova, T. G., Jean, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19872 · Cited by 29
Self-citationOncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression
Tseng, H.-Y., Chen, Y., Jen, J., Shen, P.-C., Chen, L., Lin, T.-D., Wang, Y.-C., & Hsu, H. L. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.13 · Cited by 29
Zhang, K., Ping, L., Du, T., Wang, Y., Sun, Y., Liang, G., Wang, X., Xie, X., Wei, W., Xiao, X., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9441896 · Cited by 28
Yu, K., Huang, A., Fan, L., Li, W., & Shao, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2998 · Cited by 29
Overcoming cancer treatment resistance: Unraveling the role of cancer-associated fibroblasts
Wang, X., Zhou, Y., Wang, Y., Yang, J., Li, Z., Liu, F. L., Wang, A., Gao, Z., Wu, C. H., & Yin, H. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.03.002 · Cited by 32
Singh, O., Pratt, D. W., & Aldape, K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01249-9 · Cited by 30
Jezierska‐Drutel, A., Attaran, S., Hopkins, B., Skoko, J., Rosenzweig, S. A., & Neumann, C. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6031-4 · Cited by 27
Abdel-Rafei, M. K., Thabet, N. M., Maksoud, M. I. A. A., Elkodous, M. A., Kawamura, G., Matsuda, A., Ashour, A., El-Batal, A. I., & El-Sayyad, G. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810171 · Cited by 26
Salminen, A. (2023) · Biogerontology · doi:10.1007/s10522-023-10072-9 · Cited by 27
Zou, T., Rao, J. N., Liu, L., Xiao, L., Chung, H. K., Li, Y., Chen, G., Gorospe, M., & Wang, J. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00027.2015 · Cited by 25
Chacón-Solano, E., León, C., Carretero, M., García, M., Sánchez‐Domínguez, R., Quero, F., Méndez-Jiménez, E., Bonafont, J., Ruíz‐Mezcua, B., Escamez, M. J., et al. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.06.007 · Cited by 25
The role of immunosuppressive myofibroblasts in the aging process and age-related diseases
Salminen, A. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02360-1 · Cited by 26
Olazaba, O. L., Farrow, J., & Monkkonen, T. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1304853 · Cited by 30
The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy
Li, J., Chen, L., Su, H., Yan, L., Gu, Z., Chen, Z., Zhang, A., Zhao, F., & Zhao, Y. (2019) · Nanoscale · doi:10.1039/c9nr04129j · Cited by 24
The plasticity of cancer-associated fibroblasts
Xia, Z., & Wever, O. D. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.012 · Cited by 27
Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications
Franquet, E., & Park, H. (2022) · European Journal of Radiology Open · doi:10.1016/j.ejro.2022.100455 · Cited by 22
Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis
Liang, Y., Chen, W., Zhang, Y., & Li, L. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02328-2 · Cited by 29
Liu, J., Wang, X., Deng, Y., Yu, X., Wang, H., & Li, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.766248 · Cited by 23
Metadata
- Authors
- Toullec, A., Gerald, D., Despouy, G., Bourachot, B., Cardon, M., Lefort, S., Richardson, M., Rigaill, G., Parrini, M., Lucchesi, C., Bellanger, D., Stern, M., Dubois, T., Sastre‐Garau, X., Delattre, O., Vincent‐Salomon, A., & Mechta‐Grigoriou, F.
- Affiliations
- Inserm (FR)
- Institut Curie (FR)
- Corresponding author
- Mechta‐Grigoriou, Fatima
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2010-06-01
- Volume
- 2
- Issue
- 6
- Pages
- 211-230
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3377319
- OpenAlex
- W2107028932
- Cited by
- 339
- References
- 91
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 27 · 2023: 38 · 2022: 33 · 2021: 30 · 2020: 23 · 2019: 12 · 2018: 11 · 2017: 17 · 2016: 14 · 2015: 13 · 2014: 19 · 2013: 22 · 2012: 22
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EMBO Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Institut Curie
- Fondation de France
- Agence Nationale de la Recherche
- French National Institut of Cancer
- Association pour la Recherche contre le Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- oxidative stress, JunD, myofibroblast differentiation, tumour metastasis, reactive oxygen species, mammary carcinogenesis, stromal fibroblasts, HIF-1α, CXCL12, HER2-positive breast cancer, antioxidant therapy, tumor microenvironment, hypoxia
- MeSH terms
- Animals, Breast Neoplasms, Cell Differentiation, Cell Line, Female, Fibroblasts, Histocytochemistry, Humans, Immunohistochemistry, Locomotion, Microscopy, Microscopy, Fluorescence, Models, Biological, Neoplasm Metastasis, Proto-Oncogene Proteins, Mammary Neoplasms, Animal, Incidence, Survival Analysis, Proto-Oncogene Proteins c-jun, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review